News
encourages clinical trials as an option for cancer patients. “Everyone with cancer should carefully consider all of the treatment options available for their cancer type, including standard ...
The overall five-year survival rate for colorectal cancer is around 65%. Here, a colon cancer patient looks at her ostomy bag in the mirror. Sheila – stock.adobe.com “This study adds to a ...
surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a variety of cancer types were successfully treated with only immunotherapy, according to a new study ...
A newly developed AI can predict which cancer patients are at risk for a life-threatening wasting syndrome, a new study says. The syndrome, called cachexia, accounts for about 20% of all cancer ...
An immunotherapy treatment has been found to ‘change the world’ for head and neck cancer patients by giving them an extra two and a half years before the disease worsens or comes back.
For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results. By Gina Kolata When a person ...
The event highlighted the significance of biomarkers and treatment strategies for ESR1-positive metastatic breast cancer. Patient awareness varies, with some well-informed and others skeptical of ...
Many people think of clinical trials as a last-ditch effort for cancer patients. In 2025, amid a flurry of new treatments enabling people diagnosed with cancer to live longer and better ...
Hampton University’s Proton Cancer Institute launched a new Patient Access to Help program that aims to help connect cancer patients with resources to ease their treatment process. The institute ...
Chennai: Jus' Onco, a cancer care centre in Kodambakkam launched the Jus' Onco Palliative Care Trust to offer free home-based palliative care for cancer patients. The service is for patients in ...
which affects two-thirds of breast cancer patients. Taken as a pill twice-a-day, it works by turning off a cellular ‘switch' which helps fuel cancer growth. Linda Kelly, 67, says the drug ...
Head and Neck Cancer Australia wants the major parties to commit to fund facial prostheses for cancer patients ahead of the May election. The organisation submitted a plan for a $13 million fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results